HST vs SYRE · P/E 16, rev $6.11B vs $7.60B cap
Host Hotels & Resorts Inc (HST) versus Spyre Therapeutics Inc. (SYRE) — a side-by-side from cached financials, not a winner call.
Host Hotels & Resorts Inc (HST) is a reit - hotel & motel company listed on US.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Latest reported HST revenue for 2025-12-31 was $6.11B. Net income was $765.0M. Revenue was up 7.6% from 2024-12-31 to 2025-12-31. HST currently screens at market cap $15.94B and trailing P/E 15.6.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
HST currently screens at market cap $15.94B and trailing P/E 15.6. SYRE currently screens at market cap $7.60B.
Not investment advice. Open the HST and SYRE stock pages for the full models.
Not investment advice.